29 listed drug firms see market value drop

Published: 2011-10-05 07:00:00

Updated: 2011-10-05 07:00:00

The combined market value of the KOSPI-listed 37 pharmaceutical firms by assets reached 9.31 trillion won as of end of September, down 1.52 trillion won from the end of 2010 lingering uncertainties over the financial turmoil and economic recession, Yakup.com said Monday.

But KOSDAQ-listed firm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK